FLT3 and acute myeloid leukemia: Minetto and colleagues retrospectively evaluated the efficacy of fludarabine, high-dose cytarabine, and idarubicin (FAI) in 149 newly diagnosed FLT3-ITDmut and/or NPM1mut AML (only FLT3-ITDmut = 29; FLT3-ITDmutNPM1mut = 59, only NPM1mut = 61).